Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector function

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 174-185

  Serra, Alessandro ^a,c   Nuti, Sandra ^a   Tavarini, Simona ^a   Sammicheli, Chiara ^a   Rosa, Domenico ^a   Saletti, Giulietta ^a   Soldaini, Elisabetta ^a   Abrignani, Sergio ^b   Wack, Andreas ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b National Institute of Molecular Genetics   (Italy)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD81 ANTIGEN; CD82 ANTIGEN; CD9 ANTIGEN; GLYCOPROTEIN E2; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; STAT6 PROTEIN; TETRASPANIN; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA; VIRUS RECEPTOR; CYTOKINE; LEUKOCYTE ANTIGEN;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; EFFECTOR CELL; HEPATITIS C; HEPATITIS C VIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH2 CELL; UPREGULATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; METABOLISM; PROTEIN BINDING;

ANTIGENS, CD; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; HEPACIVIRUS; HUMANS; IMMUNITY, NATURAL; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; PROTEIN BINDING;

EID: 47949111314     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.174     Document Type: Article

References (89)

1. van der Merwe, P. A., and S. J. Davis. 2003. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21: 659-684.
2. Acuto, O., and F. Michel. 2003. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3: 939-951.
3. 1, (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation. J. Immunol. 157: 1965-1972.
4. Wakkach, A., F. Cottrez, and H. Groux. 2001. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J. Immunol. 167: 3107-3113.
5. Van Seventer, G. A., Y. Shimizu, K. J. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimuiatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144: 4579-4586.
6. Levy, S., and T. Shoham. 2005. The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5: 136-148.
7. Cherukuri, A., R. H. Carter, S. Brooks. W. Bornmann, R. Finn, C. S. Dowd, and S. K. Pierce. 2004. B cell signaling is regulated by induced palmitoylation of CD81. J. Biol. Chem. 279: 31973-31982.
8. Mittelbrunn, M., M. Yanez, D. Sancho, A. Ursa, and F. Sanchez-Madrid. 2002. Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. J. Immunol. 169: 6691-6695.
9. Cherukuri, A., T. Shoham, H. W. Sohn, S. Levy, S. Brooks, R. Carter, and S. K. Pierce. 2004. The tetraspanin CD81 is necessary for partitioning of coli-gated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J. Immunol. 172: 370-380.
10. Maecker, H. T. 2003. Human CD8I directly enhances Th1 and Th2 cell activation, but preferentially induces proliferation of Th2 cells upon long-term stimulation. BMC Immunol. 4: 1.
11. Deng, J., R. H. DekruyfT, G. J. Freeman, D. T. Umetsu, and S. Levy. 2002. Critical role of CD81 in cognate T-B cell interactions leading to Th2 responses. Int. Immunol. 14:513-523.
12. Maecker, H. T., M. S. Do, and S. Levy. 1998. CD81 on B cells promotes inter-leukin 4 secretion and antibody production during T helper type 2 immune responses. Proc. Natl. Acad. Sci. USA 95: 2458-2462.
13. Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282: 938-941.
14. Houghton, M., and S. Abrignani. 2005. Prospects for a vaccine against the hepatitis C virus. Nature 436: 961-966.
15. Feld, J. J., and J. H. Hoofnagle. 2005. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436: 967-972.
16. Dustin, L. B., and C. M. Rice. 2006. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 25: 71-99.
17. Bow en, D. G., and C. M. Walker. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436: 946-952.
18. Thimme, R., D. Oldach, K. M. Chang, C. Steiger, S. C. Ray, and F. V. Chisari. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med 194: 1395-1406.
19. + T.cells in chronic hepatitis C virus infection. J. Immunol. 169: 3447-3458.
20. + T lymphocytes after infection with hepatitis C virus. J. Virol. 75: 5550-5558.
21. Wang, J., T. H. Holmes, L. L. de Guevara, R. Cheung, T. L. Wright, X. S. He, and H. B. Greenberg. 2006. Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C. J. Infect. Dis. 194: 1068-1077.
22. + T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur. J. Immunol. 31: 894-906.
23. Tsai, S. L., Y. F. Liaw, M. H.' Chen, C. Y. Huang, and G. C. Kuo. 1997. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25: 449-458.
24. Dumoulin, F. L., A. Bach, L. Leifeld, M. EI-Bakri, H. P. Fischer, T. Sauerbruch, and U. Spengler. 1997. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J. Infect. Dis. 175: 681-685.
25. Fan, X. G., W. E. Liu, C. Z. Li, Z. C. Wang, L. X. Luo, D. M. Tan. G. L. Hu, and Z. Zhang. 1998. Circulating Th1 and Th2 cytokines in patients with hepatitis C vims infection. Mediators Infiamm. 7: 295-297.
26. Crotta, S., A. Stilla, A. Wack, A. D'Andrea, S. Nuti, U. D'Oro, M. Mosca, F. Filliponi, R. M. Branetto, F. Bonino, et al. 2002. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195: 35-41.
27. Tseng, C. T., and G. R. Klimpel. 2002. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195:43-49.
28. Tseng, C. T., E. Miskovsky, and G. R. Klimpel. 2001. Crosslinking CD81 results in activation of TCR-γδ T cells. Cell Immunol. 207: 19-27.
29. Rosa, D., G. Saletti, E. De Gregorio, F. Zorat, C. Comar, U. D'Oro, S. Nuti, M. Houghton, V. Bamaba, G. Pozzato, and S. Abrignani. 2005. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. USA 102: 18544-18549.
30. Wack, A., E. Soldaini, C. Tseng, S. Nuti, G. Klimpel, and S. Abrignani. 2001. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur. J. Immunol. 31: 166-175.
31. Soldaini, E., A. Wack, U. D'Oro, S. Nutl, C. Ulivieri, C. T. Baldari, and S. Abrignani. 2003. T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by Lck. Eur. J. Immunol. 33: 455-464.
32. Muller, P., C. Renou, A. Harafa, E. Jouve, G. Kaplanski, E. Ville, J. J. Bertrand, C. Masson, T. Benderitter, and P. Halfon. 2003. Lymph node enlargement within the hepatoduodenal ligament in patients with chronic hepatitis C reflects the immunological cellular response of the host. J. Hepatol. 39: 807-813.
33. + T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 28: 3448-3455.
34. Abrignani, S. 1997. Bystander activation by cytokines of intrahepatic T cells in chronic viral hepatitis. Semin. Liver Dis. 17: 319-322.
35. Fiore, G., G. Piazzolla, V. Galetta, L. Caccetta, O. Schiraldi, and S. Antonaci. 1999. Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities. Microbios. 97: 29-38.
36. Burgio, V. L., G. Ballardini, M. Artini, M. Caratozzolo, F. B. Bianchi, and M. Levrero. 1998. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology 27: 1600-1606.
37. Mochizuki, K., N. Hayashi, K. Katayama, N. Hiramatsu, T. Kanto, E. Mita, T. Tatsumi, N. Kuzushita, A. Kasahara, H. Fusamoto, et al. 1997. B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C. Hepatology 25: 713-718.
38. Grogan, J. L., M. Mohrs, B. Harmon, D. A. Lacy, J. W. Sedat, and R. M. Locksley. 2001. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14: 205-215.
39. Heile, J. M., Y. L. Fong, D. Rosa, K. Berger, G. Saletti, S. Campagnoli, G. Bensi, S. Capo, S. Coates, K. Crawford, et al. 2000. Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates. J. Virol. 74: 6885-6892.
40. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137.
41. Krutzik, P. O., J. M. Irish, G. P. Nolan, and O. D. Perez. 2004. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin. Immunol. 110: 206-221.
42. Krutzik, P. O., and G. P. Nolan. 2003. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 55: 61-70.
43. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
44. Durie, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406-411.
45. Romagnani, S., 2000. T-cell subsets (Thl versus Th2). Ann. Allergy Asthma Immunol. 85: 9-18.
46. H2 lymphocytes. Nat. Immunol. 4: 78-86.
47. Cosmi, L., F. Annunziato, M. I. G. Galli, R. M. E. Maggi, K. Nagata, and S. Romagnani. 2000. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur. J. Immunol. 30: 2972-2979.
48. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12: A49-A53.
49. Moller, B., and P. M. Villiger. 2006. Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases. Springer Semin. Immunopathol. 27: 391-408.
50. Fehervari, Z., T. Yamaguchi, and S. Sakaguchi. 2006. The dichotomous role of IL-2: tolerance versus immunity. Trends Immunol. 27: 109-111.
51. +regulatory T cells. J. Immunol. 177: 896-904.
52. - cells to develop suppressive activity: the role of IL-2, TGF-G, and IL-10. J. Immunol. 172: 5213-5221.
53. +FoxP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 110:2983-2990.
54. Gavin, M. A., T. R. Torgerson, E. Houston, P. DeRoos, W. Y. Ho, A. Stray-Pedersen, E. L. Ocheltree, P. D. Greenberg, H. D. Ochs, and A. Y. Rudensky. 2006. Single-cell analysis of normal and FoxP3-mutant human T cells: FoxP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103: 6659-6664.
55. Dong, C., D. D. Yang, C. Tournier, A. J. Whitmarsh, J. Xu, R. J. Davis, and R. A. Flavell. 2000. JNK is required for effector T-cell function but not for T-cell activation. Nature 405: 91-94.
56. +T cells. J. Immunol. 158: 10S5-1094.
57. Kamogawa, Y., L. A. Minasi, S. R. Carding, K. Bottomly, and R. A. Flavell. 1993. The relationship of IL-4- and IFN γ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75: 985-995.
58. Unutmaz, D., P. Pileri, and S. Abrignani. 1994. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med. 180: 1159-1164.
59. +T cells. J. Exp. Med. 194: 1711-1719.
60. Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36: 897-906.
61. Tacke, M" G. Hanke, T. Hanke, and T. Hünig. 1997. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur. J. Immunol. 27: 239-247.
62. L, and the survival of primary T cells. J. Immunol. 172: 1341-1345.
63. Lagaudriere-Gesbert, C., F. Le Naour, S. Lebel-Binay, M. Billard, E. Lemichez, P. Boquet, C. Boucheix, H. Conjeaud, and E. Rubinstein. 1997. Functional analysis of four telraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol. 182: 105-112.
64. Delaguillaumie, A., J. Harriague, S. Kohanna, G. Bismuth, E. Rubinstein, M. Seigneuret, and H. Conjeaud. 2004. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation. J. Cell Sci. 117: 5269-5282.
65. Romagnani, S. 1997. The Th1/Th2 paradigm. Immunol. Today 18: 263-266.
66. Baugh, J. A., and R. Bucala. 2001. Mechanisms for modulating TNF αin immune and inflammatory disease. Curr. Opin. Drug Discov. Devel. 4: 635-650.
67. Kubo, M., M. Yamashita, R. Abe, T. Tada, K. Okumura, J. T. Ransom, and T. Nakayama. 1999. CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation. J. Immunol. 163: 2432-2442.
68. Andres, P. G., K. C. Howland, A. Nirula, L. P. Kane, L. Barron, D. Dresnek, A. Sadra, J. Imboden, A. Weiss, and A. K. Abbas. 2004. Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. Nat. Immunol. 5: 435-442.
69. August, A., and B. Dupont. 1994. Activation of sre family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. Biochem. Biophys. Res. Com-mim. 199: 1466-1473.
70. Viola, A., S. Schroeder, Y. Sakakibara, and A. Lanzavecchia. 1999. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283: 680-682.
71. +Tcells. J. Immunol. 176:3470-3479.
72. Chang, H. D., C. Helbig, L. Tykocinski, S. Kreher, J. Koeck, U. Niesner, and A. Radbruch. 2007. Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. Eur. J. Immunol. 37: 807-817.
73. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
74. Laperche, S" N. Le Marrec, A. Girault, F. Bouchardeau, A. Servant-Delmas, M. Maniez-Montreuil, P. Gallian, T. Levayer, P. Morel, and N. Simon. 2005. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J. Clin. Microbiol. 43: 3877-3883.
75. Galy, O., M. A. Petit, S. Benjelloun, P. Chevallier, M. Chevallier, P. Srivatanakul, A. Karalak, C. Carreira, N. Lyandrat, A. Essaid, et al. 2007. Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins. Cancer Lett. 248: 81-88.
76. Nakamoto, Y., S. Kaneko, M. Honda, M. Unoura, J. Cheong, A. Harada, K. Matsushima, K. Kobayashi, and S. Murakami. 1994. Detection of the putative E2 protein of hepatitis C virus in human liver. J. Med. Virol. 42: 374-379.
77. Neri, S., D. Iema, B. Mauceri, G. Abate, D. Cilio, F. Bordonaro, S. Calvagno, D. Balsamo, D. Pulvirenti, O. Magliocco, et al. 2003. Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infeclion in non-symptomatic subjects? Hepatol. Res. 27: 124-128.
78. Ierna, D., R. A. D'Amico, S. Antoci, E. Campanile, and S. Neri. 2000. Perihepatic lymphadenopathy in chronic hepatitis C: a complementary diagnostic element? J Gastroenterol. Hepatol. 15: 783-785.
79. Wynn, T. A. 2003. IL-13 effector functions. Annu. Rev. Immunol. 21: 425-456.
80. Kodera, T., T. L. McGaha, R. Phelps, W. E. Paul, and C. A. Bona. 2002. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts. Proc. Natl. Acad. Sci. USA 99: 3800-3805.
81. de Lalla, C., G. Galli, L. Aldrighetti, R. Romeo, M. Mariani, A. Monno, S. Nuti, M. Colombo, F. Callea, S. A. Porcelli, et al. 2004. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J. Immunol. 173: 1417-1425.
82. Warren, A., D. G. Le Couteur, R. Fraser, D. G. Bowen, G. W. McCaughan, and P. Bertolino. 2006. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepalology 44: 1182-1190.
83. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191: 1499-1512.
84. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101: 4260-4266.
85. Kienzle, N., K. Buttigieg, P. Groves, T. Kawula, and A. Kelso. 2002. A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CDS, perforin, and granzyme expression. J. Immunol. 168: 1672-1681.
86. Heath, V. L., L. Showe, C. Crain, F. J. Barrat, G. Trinchieri, and A. O'Garra. 2000. Cutting edge: ectopic expression of the IL-12 receptor-β2 in developing and committed Th2 cells does not affect the production of IL-4 or induce the production of IFN-γ. J. Immunol. 164: 2861-2865.
87. Nishikomori, R., R. O. Ehrhardt, and W. Strober. 2000. T helper type 2 cell differentiation occurs in the presence of interleukin 12 receptor β2 chain expression and signaling. J. Exp. Med. 191: 847-858.
88. Larrea, E., N. Garcia, C. Qian, M. P. Civeira, and J. Prieto. 1996. Tumor necrosis factor αgene expression and the response to interferon in chronic hepatitis C. Hepalology 23: 210-217.
89. Torre, F., S. Rossol, N. Pelli, M. Basso, A. Delfmo, and A. Picciotto. 2004. Kinetics of soluble tumour necrosis factor (TNF)-α receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-α alone, IFN-α plus amantadine or plus ribavirin. Clin. Exp. Immunol. 136: 507-512.